During the past decade, National Hospital Organization Matsumoto Medical Center conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 6 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Hospital Organization Matsumoto Medical Center" #1 sponsor was "Janssen Research & Development, LLC" with 7 trials, followed by "Pfizer" with 4 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Apellis Pharmaceuticals, Inc." with 1 trials sponsored and "Janssen Pharmaceutical K.K." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "National Hospital Organization Matsumoto Medical Center" are "Alzheimer Disease" (3 trials), "Alzheimer's Disease" (2 trials), "Multiple Myeloma" (2 trials), "Amyotrophic Lateral Sclerosis" (1 trials) and "Colitis, Ulcerative" (1 trials). Many other conditions were trialed in "National Hospital Organization Matsumoto Medical Center" in a lesser frequency.

Most popular intervention types in "National Hospital Organization Matsumoto Medical Center" are "Drug" (15 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Daratumumab" (3 trials), "Dexamethasone" (3 trials), "Bortezomib" (2 trials) and "Crenezumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "National Hospital Organization Matsumoto Medical Center" are 16 trials for "All" genders.

Currently, there are NaN active trials in "National Hospital Organization Matsumoto Medical Center". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in National Hospital Organization Matsumoto Medical Center, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in National Hospital Organization Matsumoto Medical Center, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".